AA
PFE icon

Altrafin AG’s Pfizer PFE Stock Holding History

Altrafin AG’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,725
Closed -$236K – 51
2025
Q2 		$236K Sell
9,725
-1,000
-9% -$23.3K 0.08% 49
2025
Q1 		$272K Hold
10,725
– – 0.11% 45
2024
Q4 		$285K Hold
10,725
– – 0.1% 47
2024
Q3 		$310K Hold
10,725
– – 0.11% 46
2024
Q2 		$300K Hold
10,725
– – 0.11% 54
2024
Q1 		$298K Sell
10,725
-360
-3% -$9.99K 0.11% 59
2023
Q4 		$319K Sell
11,085
-83,491
-88% -$2.52M 0.12% 58
2023
Q3 		$3.14M Sell
94,576
-7,126
-7% -$252K 1.37% 30
2023
Q2 		$3.73M Sell
101,702
-248
-0.2% -$9.65K 1.67% 24
2023
Q1 		$4.16M Buy
101,950
+81,623
+402% +$3.53M 2.04% 23
2022
Q4 		$1.04M Buy
20,327
+2,917
+17% +$140K 0.61% 39
2022
Q3 		$762K Buy
17,410
+6,000
+53% +$292K 0.46% 48
2022
Q2 		$598K Buy
+11,410
New +$581K 0.32% 58

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Altrafin AG's PFE Position: Q3 2025 in Review

Altrafin AG sold out of Pfizer (PFE) in Q3 2025, closing a stake of 9,725 shares — an estimated $236K sold.

Altrafin AG first reported a position in PFE in Q2 2022 and held it in 13 quarters. The position peaked at $4.16M in Q1 2023. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Altrafin AG reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Altrafin AG sold 9,725 Pfizer shares in Q3 2025, an estimated $236K.
  • Altrafin AG first reported a position in Pfizer in Q2 2022 and held it in 13 quarters.
  • Altrafin AG's Pfizer position peaked at $4.16M in Q1 2023.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Altrafin AG's 13F filing for Q3 2025, filed 17 Feb 2026.